91 related articles for article (PubMed ID: 3043449)
21. Bone marrow transplantation in the treatment of children with cancer. Current status.
Vega RA; Franco CM; Abdel-Mageed AM; Ragab AH
Hematol Oncol Clin North Am; 1987 Dec; 1(4):777-800. PubMed ID: 3323183
[TBL] [Abstract][Full Text] [Related]
22. [Intensive chemotherapy followed by autologous bone marrow transplantation in solid tumors in childhood].
de Kraker J; Voûte PA; Behrendt H
Ned Tijdschr Geneeskd; 1984 Dec; 128(49):2302-5. PubMed ID: 6392905
[No Abstract] [Full Text] [Related]
23. Results of single and double autografts for high-risk neuroblastoma patients.
Kawa-Ha K; Yumura-Yagi K; Inoue M; Park DY; Okamura T; Yasui M; Oota H; Sakata N; Yoneda M; Imura K
Bone Marrow Transplant; 1996 Jun; 17(6):957-62. PubMed ID: 8807100
[TBL] [Abstract][Full Text] [Related]
24. Development of infant botulism in a 3-year-old female with neuroblastoma following autologous bone marrow transplantation: potential use of human botulism immune globulin.
Shen WP; Felsing N; Lang D; Goodman G; Cairo MS
Bone Marrow Transplant; 1994 Mar; 13(3):345-7. PubMed ID: 8199579
[TBL] [Abstract][Full Text] [Related]
25. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
[TBL] [Abstract][Full Text] [Related]
26. Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.
D'Angio GJ; August C; Elkins W; Evans AE; Seeger R; Lenarsky C; Feig S; Wells J; Ramsay N; Kim T
Prog Clin Biol Res; 1985; 175():557-63. PubMed ID: 3887431
[No Abstract] [Full Text] [Related]
27. High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: pilot study.
Pardo N; Martí F; Fraga G; Illa J; Badell I; Peiró M; Bertran E; García J; Rueda F; Cubells J
Med Pediatr Oncol; 1996 Dec; 27(6):534-9. PubMed ID: 8888813
[TBL] [Abstract][Full Text] [Related]
28. Very long delay to engraftment after ABMT in neuroblastoma patients and effect of CD8 monoclonal antibody in vivo therapy.
Favrot MC; Philip T; Combaret V; Biron P; Morisset J; Bernard A
Prog Clin Biol Res; 1988; 271():225-36. PubMed ID: 3043450
[No Abstract] [Full Text] [Related]
29. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
[TBL] [Abstract][Full Text] [Related]
30. [Allogeneic bone marrow transplantation in a child with a stage IV neuroblastoma].
Bordigoni P; Bey P; Benz-Lemoine E; Thollot F; Schmitt M; Olive D
Ann Pediatr (Paris); 1984 Oct; 31(9):787-90. PubMed ID: 6395778
[No Abstract] [Full Text] [Related]
31. Predictive factors for the rate of engraftment of neuroblastoma patients autotransplanted with purged marrow.
Ross RE; Jeter EK; Gazitt Y; Laver J
Prog Clin Biol Res; 1994; 389():139-43. PubMed ID: 7700896
[TBL] [Abstract][Full Text] [Related]
32. Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads.
Seeger RC; Reynolds CP; Vo DD; Ugelstad J; Wells J
Prog Clin Biol Res; 1985; 175():443-58. PubMed ID: 3887429
[No Abstract] [Full Text] [Related]
33. The role of autologous bone marrow transplantation in advanced neuroblastoma.
Shuster JJ
J Clin Oncol; 1996 Sep; 14(9):2413-4. PubMed ID: 8823317
[No Abstract] [Full Text] [Related]
34. [Clinical features and prognosis of advanced neuroblastoma in children].
Gao XN; Tang SQ; Lin J
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):351-4. PubMed ID: 17706038
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone function and treatment following bone marrow transplant for neuroblastoma.
Olshan JS; Willi SM; Gruccio D; Moshang T
Bone Marrow Transplant; 1993 Oct; 12(4):381-5. PubMed ID: 8275038
[TBL] [Abstract][Full Text] [Related]
36. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
Transplant Proc; 1993 Jun; 25(3):2375-6. PubMed ID: 8516934
[No Abstract] [Full Text] [Related]
37. [Autologous bone marrow transplantation in the treatment of advanced malignant tumors in children and adolescents].
Brun del Re G; Baumgartner C; Bleher EA; Bucher U; Greiner R; Hirt A; Imbach P; Lüthi A; Odavic R; Wagner HP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):243-8. PubMed ID: 6208111
[No Abstract] [Full Text] [Related]
38. Gene marking to improve the outcome of autologous bone marrow transplantation.
Brenner MK; Rill DR
Prog Clin Biol Res; 1994; 389():587-91. PubMed ID: 7700924
[No Abstract] [Full Text] [Related]
39. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.
Yoshikawa T; Asano Y; Ihira M; Suzuki K; Ohashi M; Suga S; Kudo K; Horibe K; Kojima S; Kato K; Matsuyama T; Nishiyama Y
J Infect Dis; 2002 Apr; 185(7):847-53. PubMed ID: 11920307
[TBL] [Abstract][Full Text] [Related]
40. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
Grow WB; Moreb JS; Roque D; Manion K; Leather H; Reddy V; Khan SA; Finiewicz KJ; Nguyen H; Clancy CJ; Mehta PS; Wingard JR
Bone Marrow Transplant; 2002 Jan; 29(1):15-9. PubMed ID: 11840139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
